Skip to main content

Barbers Can Partner With Dermatologists to Augment Pseudofolliculitis Barbae Care

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 12, 2023.

By Lori Solomon HealthDay Reporter

MONDAY, Dec. 11, 2023 -- An educational intervention targeted at barbers substantially increases knowledge regarding the causes, prevention, and treatment of pseudofolliculitis barbae (PFB), according to a research letter published online Dec. 6 in JAMA Dermatology.

Xavier Rice, M.D., from the University of Texas Medical Branch in Galveston, and colleagues evaluated the effectiveness of an educational intervention as a pilot for allyship between barbers and dermatologists to address gaps in PFB care. Forty barbers were surveyed before and after an intervention, which included a comprehensive educational pamphlet on the recognition, cause, prevention, and treatment of PFB, as well as common myths and home remedies.

The researchers found that before the intervention, there was near unanimous participant understanding (97.5 percent) that Black men were the group most affected by PFB and that severe forms of PFB should be evaluated by a physician. Yet, only 30 percent of barbers correctly identified the PFB photograph in the pretest survey compared with 97.5 percent in the posttest survey. In the posttest survey, 92.5 percent of barbers recognized laser hair removal as the most effective treatment for PFB, versus only 5 percent pretest.

"Educating barbers on dermatologic conditions that disproportionately affect Black males and establishing referral services between barbers and dermatologists could serve as plausible interventions," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Bimekizumab Yields Meaningful Response in Hidradenitis Suppurativa

THURSDAY, May 30, 2024 -- Bimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published...

Tattoos May Increase Risk of Malignant Lymphoma

WEDNESDAY, May 29, 2024 -- Tattoo exposure is associated with an increased risk of several malignant lymphoma subtypes, according to a study published online in the June issue...

Acrochordons May Be Marker for Metabolic Disease in Children

TUESDAY, May 21, 2024 -- In pediatric patients, acrochordons may be a marker for metabolic disease, according to a study published online April 29 in Pediatric...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.